The impact of drug-loading factors on the solid-state form of ritonavir-mesoporous silica systems

Abina Crean

doi:10.5920/bjpharm.1150

The impact of drug-loading factors on the solid-state form of ritonavir-mesoporous silica systems

Abina Crean

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Pharmacy
DOIs	https://doi.org/10.5920/bjpharm.1150
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Ritonavir
Mesoporous silica
Dissolution
Adsorption
Materials science
Chemistry
Solvent
Drug
Chemical engineering
Nuclear chemistry
Mesoporous material
Pharmacology
Organic chemistry
Human immunodeficiency virus (HIV)
Medicine
Viral load
Virology
Catalysis
Antiretroviral therapy
Engineering

Access to Document

10.5920/bjpharm.1150

https://openalex.org/W4285043177Licence: CC BY

Cite this

@article{25e28c0ef6864dad8ac289ea615a5f51,

title = "The impact of drug-loading factors on the solid-state form of ritonavir-mesoporous silica systems",

keywords = "Ritonavir, Mesoporous silica, Dissolution, Adsorption, Materials science, Chemistry, Solvent, Drug, Chemical engineering, Nuclear chemistry, Mesoporous material, Pharmacology, Organic chemistry, Human immunodeficiency virus (HIV), Medicine, Viral load, Virology, Catalysis, Antiretroviral therapy, Engineering",

author = "Abina Crean",

year = "2022",

doi = "10.5920/bjpharm.1150",

language = "English",

journal = "British Journal of Pharmacy",

issn = "2058-8356",

}

TY - JOUR

T1 - The impact of drug-loading factors on the solid-state form of ritonavir-mesoporous silica systems

AU - Crean, Abina

PY - 2022

Y1 - 2022

KW - Ritonavir

KW - Mesoporous silica

KW - Dissolution

KW - Adsorption

KW - Materials science

KW - Chemistry

KW - Solvent

KW - Drug

KW - Chemical engineering

KW - Nuclear chemistry

KW - Mesoporous material

KW - Pharmacology

KW - Organic chemistry

KW - Human immunodeficiency virus (HIV)

KW - Medicine

KW - Viral load

KW - Virology

KW - Catalysis

KW - Antiretroviral therapy

KW - Engineering

U2 - 10.5920/bjpharm.1150

DO - 10.5920/bjpharm.1150

M3 - Article

SN - 2058-8356

JO - British Journal of Pharmacy

JF - British Journal of Pharmacy

ER -